3.335
전일 마감가:
$3.07
열려 있는:
$3.45
하루 거래량:
17.58M
Relative Volume:
17.44
시가총액:
$1.68M
수익:
$29.78M
순이익/손실:
$-39.94M
주가수익비율:
-0.0539
EPS:
-61.9139
순현금흐름:
$-16.12M
1주 성능:
-5.87%
1개월 성능:
-58.55%
6개월 성능:
-27.21%
1년 성능:
-96.74%
22nd Century Group, Inc. Stock (XXII) Company Profile
명칭
22nd Century Group, Inc.
전화
716-270-1523
주소
8560 Main Street, Williamsville, NY
XXII을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
XXII
22nd Century Group, Inc.
|
3.35 | 1.06M | 29.78M | -39.94M | -16.12M | -61.91 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
464.20 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.00 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
327.53 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
596.63 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.67 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2022-07-21 | 개시 | Alliance Global Partners | Buy |
2022-06-15 | 개시 | Craig Hallum | Buy |
2022-03-08 | 개시 | ROTH Capital | Buy |
2021-07-23 | 개시 | Cowen | Outperform |
2017-10-16 | 재확인 | Chardan Capital Markets | Buy |
2016-08-11 | 재확인 | Chardan Capital Markets | Buy |
모두보기
22nd Century Group, Inc. 주식(XXII)의 최신 뉴스
XXII Stock Surge: Time for Action? - StocksToTrade
22nd Century Group: Resurgence and Future Prospects - StocksToTrade
What catalysts could drive 22nd Century Group Inc. stock higher in 2025Get exclusive market insights for better trading - jammulinksnews.com
Is 22nd Century Group Inc. a growth stock or a value stockFree Trading Strategy Suggestions - jammulinksnews.com
22nd Century Group Inc. Stock Performance After Earnings: Historical InsightsFree AI-Powered Stock Predictions - beatles.ru
Why 22nd Century Group Inc. stock attracts strong analyst attentionFree Stock Market Insider Analysis - metal.it
How 22nd Century Group Inc. stock performs during market volatilityTrade Ready Signal - Metal.it
Should I buy 22nd Century Group Inc. stock before earningsUnprecedented profits - jammulinksnews.com
VLN Commercial Launches Confirm Viability of the FDA's Proposed Reduced Nicotine Mandate - ADVFN Brasil
What drives 22nd Century Group Inc. stock priceSkyrocketing investment returns - PrintWeekIndia
Is 22nd Century Group Inc. a good long term investmentAccelerated financial growth - Autocar Professional
What analysts say about 22nd Century Group Inc. stockExplosive wealth accumulation - jammulinksnews.com
22nd Century Group Inc. Stock Analysis and ForecastTremendous financial leverage - Autocar Professional
22nd Century Group Expands VLN Cigarette Sales Across U.S. - Tobacco Reporter
Why Did 22nd Century Group Drop 10.18% Despite FDA Approval? - AInvest
22nd Century Group hopes new reduced nicotine cigarette resonates with smokers - Greensboro News and Record
22nd Century Surges to 480th in Trading Volume with 1932% Spike Amid Major Acquisition - AInvest
XXII Secures Broader State Approvals for Product Sales Expansion - GuruFocus
22nd Century Reports Expanded State Authorization Progress to Se - GuruFocus
22nd Century Reports Expanded State Authorization Progress to Sell VLN®, Partner VLN® and Conventional Products - The Globe and Mail
22nd Century Group’s Nicotine-Reduction Progress Accelerates Market Growth - StocksToTrade
22nd Century Group shares surge 56.11% intraday after expanding VLN® low-nicotine cigarette partnerships and meeting FDA's proposed nicotine limit. - AInvest
22nd Century Group Stock Soars as FDA’s Nicotine Crackdown Sparks Opportunity - RagingBull
22nd Century Stocks: Growth or Bubble? - timothysykes.com
Why Is 22nd Century Stock (XXII) Up 85% Today? - TipRanks
22nd Century Group (XXII) Stock Soars 110.04% on FDA Compliance - AInvest
22nd Century Group Stock Jumps 75% After Hour On News Of Reduced-Nicotine Push - Benzinga
22nd Century Group stock soars after expanding VLN cigarette partnerships - Investing.com
22nd Century Group, Inc. (XXII) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):